MannKind says it is in talks with partners for Afrezza MannKind says it is in talks with partners for Afrezza and the company sees needing 6 to 8 weeks post the drug's PDUFA date to finalize any partnerships, which it expects to be royalty based or profit sharing arrangments. MannKind sees pricing Affrezza comparable to injected insulin. MannKind notes that the PDUFA date for Afrezza is July 15. Comments made earlier by CFO Matthew Pfeffer at the Goldman Sachs Global Healthcare conference.
News For MNKD From The Last 14 Days
Check below for free stories on MNKD the last two weeks.
Stocks with call strike movement; MNKD SUNE MannKind (MNKD) January 17 call option implied volatility increased 6% to 79, SunEdison (SUNE) October 28 call option implied volatility increased 3% to 58 according to IVolatility.